Novo Nordisk A/S (NOVO:CA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Insights - Novo Nordisk has appointed Mike Doustdar as the new CEO, who has been in the role for approximately 5 months and is currently revising the company's strategy [1][2]. Company Overview - Novo Nordisk has a rich history of 103 years and is recognized for its excellence in specific areas of the pharmaceutical industry [3].